Rayji Tsutsui
Interventional Cardiology · Cleveland, OHNPI 1861747255
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (32.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. 21 manufacturers reported payments, led by Shockwave Medical, Inc at 36.3% of the total. Among interventional cardiology clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 417 payments — averaging $240.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Shockwave Medical, Inc$36K
- Edwards Lifesciences$29K
- Boston Scientific$13K
- Philips North America LLC$10K
- Abbott$5K
- Abiomed$4K
- plus $5K from 15 others
Across 31 payments — averaging $3060.18 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Philips North America LLC$50K
- Boston Scientific$45K
- Eli Lilly$343
What the payments were for
- Consulting fees$31,86032%
- Speaking & faculty fees$15,24015%
- Travel & lodging$32,29132%
- Food & beverage$20,93721%
- Education$1000%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Shockwave Medical, Inc | 46 | $36,408 |
| Edwards Lifesciences | 118 | $28,581 |
| Boston Scientific | 60 | $12,671 |
| Philips North America LLC | 32 | $9,766 |
| Abbott | 46 | $4,794 |
| Abiomed | 40 | $3,625 |
| Medtronic(2 entities) | 45 | $3,085 |
| Teleflex LLC | 7 | $763 |
| Boehringer Ingelheim | 4 | $121 |
| AstraZeneca | 1 | $100 |
| Terumo Medical Corporation | 1 | $92 |
| Lantheus Medical Imaging, Inc. | 4 | $90 |
| Biotronik Inc. | 2 | $77 |
| Biosense Webster, Inc. | 3 | $74 |
| Baxter Healthcare | 1 | $69 |
| E.r. Squibb & Sons, L.L.C. | 2 | $43 |
| Asahi Intecc USA, Inc. | 1 | $20 |
| Livanova USA, Inc. | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Chiesi USA, Inc. | 1 | $13 |
| Cardiovascular Systems Inc. | 1 | $4 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$34,955
- Edwards SAPIEN 3 Transcatheter Heart Valve$13,886
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$9,989
- (9520) IGT Devices Undivided$4,642
- Watchman$2,725
- Impella$2,285
- (8328) Image Guided Therapy Devices _ Therapy$1,600
- CoreValve Evolut$1,516
- SAPIEN 3 Ultra RESILIA$1,418
- (6399) Angio iFR$1,348
- Omnilink Elite vascular stent system$1,180
- COREVALVE EVOLUT R$569
- (6574) Coronary Other$559
- (5027) Intact Vascular Und$524
- WATCHMAN Access System$484
- WATCHMAN FLX$470
- MANTA$383
- Resolute$276
- GENERAL - STENTS$272
- DRAGONFLY OPSTAR$261
How this compares
$100,428 in reported general payments places this provider in the 90th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 37 | $53,912 |
| EliquisApixaban | 49 | $51,209 |
| JardianceEmpagliflozin | 31 | $41,484 |
| Atorvastatin Calcium | 195 | $7,335 |
| Ezetimibe | 42 | $3,135 |
| ClopidogrelClopidogrel Bisulfate | 98 | $2,230 |
| Losartan Potassium | 88 | $1,679 |
| Metoprolol Succinate | 108 | $1,670 |
| Rosuvastatin Calcium | 35 | $1,472 |
| Amlodipine Besylate | 59 | $713 |
| Carvedilol | 58 | $564 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 25 | $549 |
| Nitroglycerin | 46 | $466 |
| Metoprolol Tartrate | 32 | $306 |
| Pravastatin Sodium | 11 | $240 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $121 | $41,48431 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 256 interventional cardiology providers in Ohio.
Other interventional cardiology in Cleveland
- Grant ReedCleveland$235K
- Rishi PuriCleveland$185K
- Paul PoommipanitCleveland$97K
- Jun LiCleveland$85K
- Michael ChenierCleveland$76K
- Khaled ZiadaCleveland$53K
- Laura YoungCleveland$51K
- Bernardo CorteseCleveland$45K
- Jason WenCleveland$37K
- Khanjan ShahCleveland$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.